Windrose Health Investors, LLC

WindRose Health Investors, LLC advises private equity funds and related co‑investment vehicles that invest primarily in U.S. middle‑market healthcare companies. The firm manages pooled institutional capital (about $7.01 billion in discretionary AUM as of December 31, 2025) and does not serve individual retail advisory accounts.

The adviser seeks control or significant‑influence positions in profitable, cost‑efficient healthcare businesses across many niche segments (it estimates more than 120 sub‑sectors) and pursues consolidation opportunities through active portfolio management, board placement and operational support. WindRose describes a disciplined deal‑sourcing and vetting process that overlays its network on sector analysis and discloses the use of AI and machine‑learning tools to assist due diligence and investment activities.

What stands out relative to many peers is the firm’s affiliation with a broker‑dealer—MTS Securities, LLC—under which certain management persons may be registered representatives when appropriate, and its ongoing strategic investor relationship in which the Strategic Investor remains a fund investor and receives a portion of carried interest. The firm also recently launched and raised a new fund (per its March 31, 2026 filing) and discloses governance features such as advisory committees, co‑investment arrangements and management‑fee offsets for certain portfolio‑company fees that can affect allocation and information rights.